5244042026-08-045244042026-08-042026-08-04ResolutionOrAgendaDomain15244042026-08-04ResolutionOrAgendaDomain15244042026-08-042026-08-04ResolutionOrAgendaDomain25244042026-08-04ResolutionOrAgendaDomain25244042026-08-042026-08-04ResolutionOrAgendaDomain35244042026-08-04ResolutionOrAgendaDomain35244042026-08-042026-08-04ResolutionOrAgendaDomain45244042026-08-04ResolutionOrAgendaDomain4xbrli:pureMARKSANS PHARMA LIMITEDMARKSANSNew2026-07-0311:50:002026-08-04Annual General MeetingVideo Conference (VC) or Other Audio-Visual Means (OAVM)1Thursday2026-08-2711:00:00Mumbai4Ordinary ResolutionAdoption of Financial StatementsTo consider and adopt the audited standalone financial statements of the Company together with the report of the Board of Directors and the Auditors thereon for the financial year ended March 31, 2026 and audited consolidated financial statements of the Company together with the report of the Auditors thereon for the financial year ended March 31, 2026.Ordinary ResolutionIssuance/Corporate ActionDividendTo declare dividend on equity shares recommended by the Board of Directors at its meeting held on 26 May 2026. The Board of Directors has recommended final dividend of H 0.90 (90%) per equity share of Re. 1/- each face value.Ordinary ResolutionOthersOthersTo appoint a director in place of Dr. Sunny Sharma (DIN:02267273) who retires by rotation and being eligible, offers himself for re-appointment.To appoint a director in place of Dr. Sunny Sharma (DIN:02267273) who retires by rotation and being eligible, offers himself for re-appointment.Special ResolutionAppointment/Re-appointment/Removal/Ratification/Retirement/RemunerationRe-appointmentTo approve the re-appointment of and remuneration to Mrs. Sandra Saldanha (DIN: 00021023) as a Whole-time Director of the Company for a further period of Three (3) years with effect from 25th September, 2026Executive DirectorMrs. Sandra Saldanha000210232026-09-252029-09-245